Interestingly, the group of Yi et al. reported a novel mechanism by which oncogenic activation of the MTOR signaling pathway suppresses ferroptosis in cancer cells via SREBF1-mediated lipogenesis, and demonstrated the potential therapeutic application of combining MTORC1 inhibition with ferroptosis induction in cancer treatment [145]. The gene discussed is SREBF1; the disease is cancer.